Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families.

Inflammatory bowel diseases - 1 Feb 2001

Vermeire S, Peeters M, Vlietinck R, Joossens S, Den Hond E, Bulteel V, Bossuyt X, Geypens B, Rutgeerts P

Abstract excerpt

BACKGROUND: Serologic markers anti-Saccharomyces cerevisiae antibodies (ASCA) and antineutrophil cytoplasmic antibodies with perinuclear staining (pANCA) have been proposed to study the immunopathogenesis of IBD. Their measurement may allow better phenotyping of the disease and the detection of s...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Bacterial
Share to Biomarkers
Share to Chelating Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Digestive System

Share to Edetic Acid

Share to Inflammatory Bowel Diseases

Share to Permeability

Share to Saccharomyces cerevisiae

Source

Identifiers

PMID: 11233666
DOI: 10.1097/00054725-200102000-00002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-11233666-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families.PMID 11233666Read ↗

Anti-Saccharomyces cerevisiae antibodies status is associated with oral involvement and disease severity in Crohn disease.Semantic proximity Read ↗

Anti-saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease and their first-degree relatives: potential clinical value.Semantic proximity Read ↗

Diagnostic utility, disease activity, and disease phenotype correlation of serum ASCA, pANCA, and PR3-ANCA in pediatric inflammatory bowel disease.Semantic proximity Read ↗

Diagnostic utility and phenotype correlation of serum ASCA and ANCA in pediatric inflammatory bowel diseaseSemantic proximity Read ↗

Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease.Semantic proximity Read ↗

Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations.Semantic proximity Read ↗

Significance of anti-sacharomices cerevisiae antibodies (ASCA) in patients with inflammatory bowel diseases in Romania.Semantic proximity Read ↗

Variation of Gut Mucosal Microbiome With Anti‐Saccharomyces cerevisiae Antibody Status in Pediatric Crohn DiseaseSemantic proximity Read ↗

Association of Anti-Saccharomyces cerevisiae antibodies with clinical phenotype in spondyloarthritis patients.Semantic proximity Read ↗

Negative association between smoking and anti-saccharomyces cerevisiae antibodies in Crohn's disease.Semantic proximity Read ↗

Anti-Saccharomyces cerevisiae antibodies associate with phenotypes and higher risk for surgery in Crohn's disease: a meta-analysis.Semantic proximity Read ↗

Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.